However, there was no statistically significant difference in G9053A and G8485A rates between breast cancer patients and controls as well as between mtDNA alterations and the urlological features of breast cancer such as age, size of tumors, number of lymph nodes, size of lymph nodes, T stage, N stage, tumor differentiation and stages of disease.